Cat.#: ACPP-1135
| Despition | ACTH Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1394 | Human BPNT1 Protein (AC1394) | 2 µg | inquiry |
| ACPP-1190 | ADCY6 Blocking Peptide (AC1190) | 250 µg | inquiry |
| ACPP-1756 | Human TSH Protein (AC1756) | 2 µg | inquiry |
| ACPP-1612 | Human Vimentin Protein, GST (AC1612) | 2 µg | inquiry |
| ACPP-1360 | Human GAD65 Protein (AC1360) | 1 mg | inquiry |
| ACPP-1625 | Human POMC Protein (AC1625) | 2 µg | inquiry |
| ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
| ACPP-1149 | Recombinant Human TNF Receptor II Protein (Fc Tag) (AC1149) | 50 µg | inquiry |
| ACPP-1280 | SRPX2 Blocking Peptide (AC1280) | 250 µg | inquiry |
| ACPP-1544 | Human GAPDH Protein (AC1544) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.